Ramucirumab + Paclitaxel (Second-line)
Treatment used for 1 condition
Total Trials
16
Total Participants
5K
Avg Effectiveness
65%
Avg Safety Score
30%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.